Market revenue in 2023 | USD 14.8 million |
Market revenue in 2030 | USD 27.0 million |
Growth rate | 8.9% (CAGR from 2023 to 2030) |
Largest segment | Transbronchial needle aspiration (tbna) needles |
Fastest growing segment | Transbronchial Needle Aspiration (TBNA) Needles |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biopsy Forceps, Transbronchial Needle Aspiration (TBNA) Needles, Cytology Brushes |
Key market players worldwide | Olympus Corp, Boston Scientific Corp, Conmed Corp, Medtronic PLC, Becton Dickinson & Co, Hobbs Medical, Cook Medical, Telemed Systems, Argon Medical Devices, Horizons International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bronchial biopsy devices market will help companies and investors design strategic landscapes.
Transbronchial needle aspiration (tbna) needles was the largest segment with a revenue share of 67.57% in 2024. Horizon Databook has segmented the UK bronchial biopsy devices market based on biopsy forceps, transbronchial needle aspiration (tbna) needles, cytology brushes covering the revenue growth of each sub-segment from 2018 to 2030.
The UK bronchial biopsy devices market is characterized by a strong focus on early detection & diagnosis of lung diseases. This is driven by national healthcare initiatives such as the NHS Long Term Plan, which emphasizes the importance of early cancer detection.
The market benefits from the UK’s advanced healthcare infrastructure, particularly in cities like London and Manchester, where leading medical institutions employ state-of-the-art bronchial biopsy devices. Companies such as Pentax Medical and Cook Medical have a significant presence in the UK, providing a range of devices tailored to the specific needs of the British healthcare system.
The growing incidence of lung cancer in the UK, one of the highest in Europe, is another major factor expected to improve the demand for bronchial biopsy procedures. The UK government has launched several public health campaigns aimed at raising awareness of lung disease symptoms, leading to increased screening and diagnosis rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK bronchial biopsy devices market , including forecasts for subscribers. This country databook contains high-level insights into UK bronchial biopsy devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account